You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: 6,288,095


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,288,095
Title: Compounds
Abstract:A method is provided for the treatment and/or prophylaxis of cardiovascular diseases or eating disorders in a human or non-human mammal, which comprises administering to a human or non-human mammal in need thereof, an effective, non-toxic amount of a compound of formula (I): ##STR1## or a tautomeric form thereof and/or a pharmaceuticlaly acceptable salt thereof and/or a pharmaceutically acceptable solvate thereof, in which A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6.
Inventor(s): Hindley; Richard Mark (Epsom, GB), Cawthorne; Michael Antony (Epsom, GB)
Assignee: Beecham Group p.l.c. (GB)
Application Number:08/358,327
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Dosage form;
Patent landscape, scope, and claims:

United States Patent 6,288,095: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,288,095, titled "Compounds," is a patent that has significant implications in the fields of pharmaceuticals and biomedical research. This patent, issued to treat certain medical conditions, provides a comprehensive look into the world of patent claims, scope, and the broader patent landscape.

Patent Overview

Publication Details

  • Patent Number: US6288095B1
  • Authority: United States
  • Publication Date: October 11, 2001
  • Application Number: US08/358,327
  • Prior Art Date: February 10, 1995[4][5].

Patent Description

The patent describes compounds, particularly those related to thiazolidinediones, which are used in the treatment of various medical conditions. These compounds are known for their therapeutic effects, especially in regulating appetite and food intake, and in the treatment of certain eating disorders and cardiovascular diseases[4][5].

Scope of the Patent

Claims

The patent includes multiple claims that define the scope of the invention. Here are some key aspects:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe a specific compound or a class of compounds with particular structural features.
  • Dependent Claims: These claims narrow down the scope by adding additional limitations to the independent claims. For instance, a dependent claim might specify a particular method of synthesizing the compound or a specific use of the compound[4].

Claim Analysis

To understand the scope, it is crucial to analyze each claim individually and in relation to the dependent claims.

  • Claim 1: Typically, this is the broadest claim and sets the foundation for the invention. It might describe a general formula for the compounds.
  • Dependent Claims: These claims build upon the independent claims by adding specific details such as the substitution of certain groups, the method of preparation, or the specific use of the compound.

Patent Claims Research Dataset

For a deeper analysis, the USPTO's Patent Claims Research Dataset can be useful. This dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. It includes claim-level statistics and document-level statistics, which can help in understanding the scope and trends of patent claims[3].

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to look at related patents and applications. Tools like the USPTO's Patent Public Search and the Global Dossier can be used to identify patent families and related applications filed at participating IP Offices.

  • Global Dossier: This service allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices, along with the dossier, classification, and citation data[1].

International Patent Offices

Searching international patent databases is crucial to ensure that the invention is novel and non-obvious globally.

  • European Patent Office (EPO): The esp@cenet network provides access to Europe's patent databases and includes machine translations for some languages[1].
  • Japan Patent Office (JPO): Similar to the EPO, the JPO provides access to Japanese patents with machine translations[1].
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE® Search Service offers a full-text search of published international patent applications and includes machine translations for some documents[1].

Prior Art and Citation Analysis

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

Prior Art Keywords

Analyzing prior art keywords such as "amino," "methyl," "complex," and "thiazolidinedione" can provide insights into the existing technological landscape and help in identifying potential overlaps or innovations[4].

Legal Status and Expiration

Current Status

The patent US6288095B1 has expired, as indicated by its legal status. This means that the exclusive rights granted by the patent are no longer in effect, and the invention is now in the public domain[4][5].

Practical Implications

Public Domain

With the patent having expired, the compounds and methods described can now be freely used, manufactured, and sold without infringing on the original patent. This can lead to increased competition and potentially lower prices for related products.

Research and Development

Researchers and developers can build upon the knowledge disclosed in the patent without needing to obtain a license. This can accelerate innovation in related fields.

Key Takeaways

  • Patent Scope: The scope of US6288095B1 is defined by its claims, which include specific compounds and methods for their use.
  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the patent's scope.
  • Patent Landscape: The patent is part of a broader landscape that includes related patents and applications globally.
  • Prior Art: Analyzing prior art and citations helps in understanding the novelty and non-obviousness of the invention.
  • Legal Status: The patent has expired, making the invention public domain.

FAQs

Q: What is the main subject of United States Patent 6,288,095?

A: The main subject is compounds, particularly thiazolidinediones, used in treating certain medical conditions such as eating disorders and cardiovascular diseases.

Q: How can I analyze the scope of the patent?

A: Analyze the independent and dependent claims to understand the scope. Use tools like the USPTO's Patent Claims Research Dataset for deeper insights.

Q: Is the patent still in effect?

A: No, the patent has expired, and the invention is now in the public domain.

Q: What are the implications of the patent's expiration?

A: The expiration means that the compounds and methods described can be freely used, manufactured, and sold without infringing on the original patent.

Q: How can I find related patents and applications?

A: Use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the EPO, JPO, and WIPO.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - WO2004096237A2: https://patents.google.com/patent/WO2004096237
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US6288095B1: https://patents.google.com/patent/US6288095B1/en
  5. Unified Patents - US-6288095-B1: https://portal.unifiedpatents.com/patents/patent/US-6288095-B1

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,288,095

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,288,095

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8720825Sep 04, 1987
United Kingdom8727987Nov 30, 1987
United Kingdom8802454Feb 04, 1988

International Family Members for US Patent 6,288,095

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 186724 ⤷  Try for Free
European Patent Office 0306228 ⤷  Try for Free SPC/GB01/002 United Kingdom ⤷  Try for Free
European Patent Office 0306228 ⤷  Try for Free 2001C/004 Belgium ⤷  Try for Free
European Patent Office 0306228 ⤷  Try for Free C300034 Netherlands ⤷  Try for Free
European Patent Office 0306228 ⤷  Try for Free 38/2000 Austria ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.